High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis
- 18 February 2026
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (8) , 5903-5911
Abstract
Pancreatic cancer remains one of the most challenging malignancies to diagnose and treat due to the late development of symptoms and limited early diagnostic options. Intraductal papillary mucinous neoplasms (IPMNs) are noninvasive precursors to invasive pancreatic ductal adenocarcinoma (PDAC), and an understanding of the changes in patterns of protein expression that accompany the progression from normal ductal (ND) cells to IPMN and PDAC may provide avenues for improved earlier detection. In this study, we present an optimized spatial tissue proteomics workflow, termed SP-Max (Spatial Proteomics Optimized for Maximum Sensitivity and Reproducibility in Minimal Sample), designed to maximize protein recovery and quantification from limited laser microdissected (LMD) samples. Our workflow enabled the identification of more than 6000 proteins and the quantification of over 5200 protein groups from FFPE tissue contours of pancreatic tissues. Comparative analyses across ND, IPMN, and PDAC revealed critical molecular differences in protein pathways and potential markers of progression. SP-Max provides a systematic, reproducible approach that markedly enhances our ability to study precancerous lesions and cancer progression in pancreatic tissues at high resolution.Keywords
All Related Versions
Funding Information
- National Cancer Institute (U01CA274514)
- National Cancer Institute (U24CA271079)
- National Cancer Institute (U2CCA271895)
This publication has 44 references indexed in Scilit:
- Exploring the function and prognostic value of RPLP0, RPLP1 and RPLP2 expression in lung adenocarcinomaJournal of Molecular Histology, 2024
- ZBTB7A interferes with the RPL5‐P53 feedback loop and reduces endoplasmic reticulum stress‐induced apoptosis of pancreatic cancer cellsMolecular Carcinogenesis, 2024
- Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical studyMedcomm, 2023
- The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detectionMass Spectrometry Reviews, 2021
- Mitochondrial respiratory supercomplexes in mammalian cells: structural versus functional roleJournal of Molecular Medicine, 2020
- Recent advances and opportunities in proteomic analyses of tumour heterogeneityThe Journal of Pathology, 2018
- Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030Cancer Medicine, 2016
- Molecular Pathogenesis of Pancreatic Cancer2016
- Oxidative stress in apoptosis and cancer: an updateArchives of Toxicology, 2012
- Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus studyVirchows Archiv, 2005